Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
3.360
-0.130 (-3.72%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Sensus Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17.51 | 27.48 | 41.81 | 24.41 | 44.53 | 27.04 | |
Revenue Growth | -53.39% | -34.27% | 71.30% | -45.20% | 64.68% | 182.36% |
Cost of Revenue | 11.14 | 15.62 | 17.38 | 10.35 | 14.9 | 10.05 |
Gross Profit | 6.37 | 11.87 | 24.43 | 14.06 | 29.63 | 16.99 |
Selling, General & Admin | 13.23 | 14.4 | 12.13 | 10.76 | 11.34 | 9.43 |
Research & Development | 6.4 | 7.78 | 4.22 | 3.68 | 3.46 | 3.44 |
Operating Expenses | 19.63 | 22.17 | 16.34 | 14.44 | 14.8 | 12.87 |
Operating Income | -13.26 | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 |
Interest Expense | - | - | - | - | - | -0 |
Interest & Investment Income | 0.56 | 0.68 | 0.93 | 0.99 | 0.38 | 0 |
EBT Excluding Unusual Items | -12.7 | -9.62 | 9.02 | 0.61 | 15.21 | 4.12 |
Gain (Loss) on Sale of Assets | - | - | - | 0.04 | 12.78 | -0 |
Pretax Income | -12.7 | -9.62 | 9.02 | 0.65 | 27.99 | 4.12 |
Income Tax Expense | 2.79 | -1.91 | 2.38 | 0.17 | 3.75 | - |
Net Income | -15.49 | -7.72 | 6.65 | 0.49 | 24.24 | 4.12 |
Net Income to Common | -15.49 | -7.72 | 6.65 | 0.49 | 24.24 | 4.12 |
Net Income Growth | - | - | 1270.51% | -98.00% | 488.59% | - |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 17 | 17 |
Shares Change | 0.39% | -0.20% | 0.57% | -2.12% | 0.70% | 0.42% |
EPS (Basic) | -0.94 | -0.47 | 0.41 | 0.03 | 1.47 | 0.25 |
EPS (Diluted) | -0.94 | -0.47 | 0.41 | 0.03 | 1.46 | 0.25 |
EPS Growth | - | - | 1266.06% | -97.96% | 484.00% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.97 | 0.33 | -1.11 | -2.37 | -1.57 | -0.41 |
Free Cash Flow Per Share | -0.42 | 0.02 | -0.07 | -0.15 | -0.10 | -0.03 |
Gross Margin | 36.39% | 43.18% | 58.44% | 57.61% | 66.53% | 62.82% |
Operating Margin | -75.71% | -37.51% | 19.35% | -1.57% | 33.30% | 15.24% |
Profit Margin | -88.45% | -28.09% | 15.90% | 1.99% | 54.44% | 15.23% |
Free Cash Flow Margin | -39.82% | 1.21% | -2.65% | -9.73% | -3.53% | -1.53% |
EBITDA | -12.87 | -9.92 | 8.33 | -0.11 | 15.15 | 4.73 |
EBITDA Margin | -73.52% | -36.10% | 19.92% | -0.44% | 34.01% | 17.50% |
D&A For EBITDA | 0.38 | 0.39 | 0.24 | 0.28 | 0.32 | 0.61 |
EBIT | -13.26 | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 |
EBIT Margin | -75.71% | -37.50% | 19.35% | -1.57% | 33.30% | 15.24% |
Effective Tax Rate | - | - | 26.32% | 25.61% | 13.38% | - |
Advertising Expenses | - | 2 | 1.2 | 1.2 | 0.9 | 0.46 |